ÕÒÂÛÎÄÍø > ҽҩѧÂÛÎÄ > ҽѧÂÛÎÄ >

¸ÊÜÎÒæÉö¶³¸É·Û¶ÔÉö²¡×ÛºÏÕ÷Ä£ÐÍ´óÊóµÄÖÎÁÆ×÷ÓÃ(1)

     ×÷Õß:ÕÔ°®¹ú£¬ÀµÐ¡Æ½£¬Óڷ壬ËνðÉ­

¡¾ÕªÒª¡¿  Ä¿µÄ  ¿¼²ì¸ÊÜÎÒæÉö¶³¸É·Û¶Ô°¢Ã¹ËØÐÍÉö²¡×ÛºÏÕ÷Ä£ÐÍ´óÊóÄòµ°°×¡¢Ñª½¬°×µ°°×¡¢µ¨¹Ì´¼¡¢¸ÊÓÍÈýõ¥µÄ Ó°Ïì £¬¹Û²ìÆä¶ÔʵÑéÐÔ´óÊóÉö²¡×ÛºÏÕ÷µÄ ÖÎÁÆ ×÷Óᣠ·½·¨   Óð¢Ã¹ËØÖƱ¸´óÊóÉö²¡×ÛºÏÕ÷Ä£ÐÍ£¬¶Ô¸÷×é´óÊó·Ö±ð¸øÓèÉúÀíÑÎË®¡¢Ç¿µÄËÉÒÔ¼°²»Í¬¼ÁÁ¿¸ÊÜÎÒæÉö¶³¸É·Û£¬ÓÚ¸øÒ©ºó²»Í¬Ê±¼ä²â¶¨´óÊó24hÄòÁ¿¡¢×ܵ°°×Á¿£¬ÊµÑé½áÊøÊ±²â¶¨¸÷×é´óÊóѪ½¬°×µ°°×¡¢µ¨¹Ì´¼¡¢¸ÊÓÍÈýõ¥º¬Á¿¡£½á¹û  ¸øÓè¶³¸É·Û5Öܺó¸÷ÖÎÁÆ×é24h×ÜÄòÁ¿±ÈÄ£ÐÍ×éÃ÷ÏÔÌá¸ß£¨p£¼0.05£©£»24hÄòµ°°×Á¿ÔÚ¸øÒ©ºó2¡¢3¡¢4ÖÜÏÔÖøÏ½µ£¨p£¼0.05£©£»Æä×÷ÓÃÇ¿¶ÈÓÐÃ÷ÏÔ¼ÁÁ¿ÒÀÀµ¹ØÏµ£¬µ«µÍ¼ÁÁ¿×éÖÎÁÆ5Öܺó24hÄòµ°°×Á¿ÓëÄ£ÐÍ×éÎÞÃ÷ÏÔ²îÒ죨p£¾0.05£©£»¸ÊÜÎÒæÉö¶³¸É·ÛÖÎÁÆ5ÖÜ¿ÉÃ÷ÏÔÉý¸ßÄ£ÐÍ´óÊóѪ½¬°×µ°°×£¨p£¼0.05£©£¬½µµÍµ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥Ë®Æ½£¨p£¼0.05£©£»¶øÇ¿µÄËÉÔÚÉý¸ßÄ£ÐÍ´óÊóѪ½¬°×µ°°×¡¢½µµÍµ¨¹Ì´¼£¨p£¼0.05£©µÄͬʱ£¬ÒýÆð¸ÊÓÍÈýõ¥Ë®Æ½µÄÏÔÖøÉÏÉý£¨p£¼0.05£©¡£½áÂÛ  ¸ÊÜÎÒæÉö¶³¸É·Û¿ÉÏÔÖø¸ÄÉÆÊµÑéÐÔÉö²¡×ÛºÏÕ÷´óÊó¸÷ÏîÉú»¯Ö¸±ê£¬¶ÔÉö²¡×ÛºÏÕ÷ÓÐÈ·ÇеÄÖÎÁÆ×÷Óá£
   
    ¡¾¹Ø¼ü´Ê¡¿  ¸ÊÜÎÒæÉö¶³¸É·Û£»Éö²¡×ÛºÏÕ÷£»ÊµÑé
   
    the rapeutic effect of ganqiyishen powder on rats with experimental nephrotic syndrome
        
    ¡¾abstract¡¿  objective  to evaluate the therapeutic effect of ganqiyishen powder on rat with experimental nephrotic syndrome according to the levels of urine protein£¬plasma albumin£¬cholesterol and triglyceride in pathological modeled animals.methods  rat¡¯s nephrotic syndrome model were prepared with adriamycin infusion through tail vein£¬saline or prednisone or different dosage of ganqiyishen powder was administrated to the rats after the nephrotic syndrome model was prepared successfully£¬total volume of urine excreted in 24h was measured after treated with different therapeutic agents at the 2nd and 5th weekend£¬and the urine protein level at the 2nd£¬3rd£¬4th and 5th weekend was assayed respectively  plasma albumin£¬cholesterol and triglyceride were  analyzed with full automatic blood bio-chem analyzer.therapeutic effect of ganqiyishen powder was evaluated based upon the results mentioned above.results  total 24h urine volume were elevated after treatment£¬the difference between the powder treated groups and the model group was significant (p£¼0.05)£¬urine protein in powder treated groups were decreased at the 2nd£¬3rd£¬4th and 5th weekend compared with those of model group (p£¼0.05).having been treated with ganqiyishen powder for 5wk£¬plasma albumin was elevated (p£¼0.05) but cholesterol and triglyceride were decreased obviously (p£¼0.05).as to the prednisone treated group£¬both plasma albumin and triglyceride were elevated (p£¼0.05)£¬while the cholesterol was decreased significantly (p£¼0.05).conclusion  ganqiyishen powder could improve the biochemistry index of nephrotic syndrome rats£¬and the therapeutic effect of the powder on rat¡¯s nephrotic syndrome was obvious.
   
    ¡¾key words¡¿  ganqiyishen powder£»nephrotic syndrome£»experiment
   
    ¸ÊÜÎÒæÉöË®¼å¼ÁÒÑÔÚÁÙ´² Ó¦Óà ʮÓàÄ꣬¶ÔÉö²¡×ÛºÏÕ÷£¨nephrotic syndrome£¬ns£©µÄÁÙ´²ÖÎÓúÂʸߴï90%ÒÔÉÏ£¬ÁÆÐ§ÏÔÖø¡£ÌرðÓÐÒâÒåµÄÊÇ£¬ÆäÖжàÊý»¼ÕßΪÄÑÖÎÐÔns£¬Òò´ËÊÇÒ»ÖÖÓй㷺ӦÓÃǰ¾°µÄDZÔÚnsÖÎÁÆÒ©Îï¡£ÔçÆÚ Ñо¿ ֤ʵ£¬¸ÊÜÎÒæÉöË®¼å¼ÁµÄÖ÷ÒªÓÐЧ³É·ÖΪÉúÎï¼îÀàÎïÖÊ£¬±¾ÊµÑéµÄÄ¿µÄÔÚÓÚ¿¼²ìÓÉ×ÜÉúÎï¼îÖÆ±¸µÄ¶³¸É·Û¶ÔÉö²¡×ÛºÏÕ÷Ä£ÐÍ´óÊóÄòµ°°×¡¢Ñª½¬°×µ°°×¡¢µ¨¹Ì´¼ÒÔ¼°¸ÊÓÍÈýõ¥µÈÉú»¯Ö¸±êµÄÓ°Ï죬¹Û²ìÆä¶ÔʵÑéÐÔ´óÊónsµÄÖÎÁÆ×÷Óã¬Îª¸ÊÜÎÒæÉö¶³¸É·ÛµÄÁÙ´²Ó¦ÓÃÌṩÒÀ¾Ý¡£
   
    1  ²ÄÁÏÓë·½·¨
   
    1.1  Ò©Îï  ´×ËáÇ¿µÄËÉÆ¬£¬¹ã¶«»ªÄÏÖÆÒ©³§£¬¹æ¸ñ5mg/Ƭ£¬ÅúºÅ£º020716£»ÑÎËá°¢Ã¹ËØ£¨adriamycin£¬adr£©£¬ÈÕ±¾ÃÀ¶ÏãÖêʽ»áÉ磬¹æ¸ñ10mg/Ö§£¬ÅúºÅ£º0109e1£»¸ÊÜÎÒæÉö¶³¸É·Û£º½â·Å¾ü150 Ò½Ôº Ìṩ¡£
   
    1.2  ¶¯Îï  ÐÛÐÔ½¡¿µsd´óÊó£¬ÌåÖØ170¡À30g£¬¹º×ÔÂåÑôҽѧ¸ßµÈר ¿ÆÑ§ УʵÑ鶯ÎïÖÐÐÄ£¬±ê×¼ËÇÁÏÊÊÓ¦»·¾³1Öܺó¹©ÊµÑéÓá£
   
    1.3  nsÄ£ÐÍÖÆ×÷  °¢Ã¹ËØÐÍ´óÊónsÄ£ÐͲÎÕÕ ÎÄÏ× £Û1£ÝÖÆ×÷¡£¾ßÌå·½·¨£ºadr7.5mg/kg·Ö2´Î¸øÓèÇåÐÑ״̬ÏÂsd´óÊó£¬ÒÔβ¾²Âö×¢É䷽ʽ¸øÒ©¡£ÊµÑéd1×¢Éäadr 4mg/kg£¬d8ÔÙ´Î×¢Éäadr 3.5mg/kg£¬¶ÔÕÕ×éÓÃÏàͬ·½·¨×¢ÉäÏàÓ¦¼ÁÁ¿ÉúÀíÑÎË®¡£
   
    1.4  ʵÑé·Ö×é¼°¸øÒ©  ÔìÄ£´óÊóÓÚµÚ2´Î¸øÓèadrºó£¬Ëæ»ú·ÖΪ6×飬ÿ×é10Ö»¡£·Ö±ðΪ£º£¨1£©¿Õ°×¶ÔÕÕ×飻£¨2£©Ä£ÐÍ×飻£¨3£©Ç¿µÄËɸøÒ©×飨20¦Ìg/100g£©£»£¨4£©¸ÊÜÎÒæÉö¶³¸É·Û¸ß¼ÁÁ¿×飨2.0mg/100g£©£»£¨5£©¸ÊÜÎÒæÉö¶³¸É·ÛÖмÁÁ¿×飨1.0mg/100g£©£»£¨6£©¸ÊÜÎÒæÉö¶³¸É·ÛµÍ¼ÁÁ¿×飨0.5mg/100g£©¡£ÊÜÊÔ¶¯ÎïÔìÄ£ºó£¬¸÷×é°´ÉÏÊö¼ÁÁ¿Ã¿Ìì¹àθ¸øÒ©1´Î£¬¿Õ°××éºÍÄ£ÐÍ×鏸ÓèµÈÁ¿ÉúÀíÑÎË®£¬Á¬Ðø¸øÒ©4ÖÜ£¬Õû¸öʵÑé¹ý³ÌΪ5ÖÜ¡£
   
    1.5  ¹Û²ìÖ¸±ê¼°²â¶¨·½·¨
   
    1.5.1  Ò»°ãÇé¿ö  ¹Û²ì´óÊóµÄ¾«Éñ×´¿ö¡¢ÌåÖØ¸Ä±ä¡¢Ìåë¡¢ÒûË®¡¢»î¶¯¡¢Ë®Ö×Çé¿öÒÔ¼°²â¶¨24h×ÜÄòÁ¿¡£
   
    1.5.2  ÄòÒº¼ì²é  24hÄòµ°°×²â¶¨£º¸÷×é´óÊó·Ö±ðÓÚʵÑéµÚ2¡¢3¡¢4¡¢5ÖÜÖôúлÁýÖУ¬ÊÕ¼¯24hÄòÒº£¬¿¼Âí˹ÁÁÀ¶±ÈÉ«·¨²â¶¨Äòµ°°×Á¿¡£
   
    1.5.3  ѪҺ¼ì²é  ʵÑéµÚ5ÖÜÄ©£¬ÔÚÒÒÃÑÂé×í״̬Ï£¬´Ó´óÊóÑÛ¾²Âö´ÔȡѪ£¬ÖÃÈ«×Ô¶¯ÑªÒº ·ÖÎö ÒÇ£¨ce-ll-dyn3500ÐÍ£¬ÑÅÅ๫˾£©²â¶¨Ñª½¬°×µ°°×¡¢×ܵ¨¹Ì´¼¡¢¸ÊÓÍÈýõ¥Ë®Æ½¡£
   
    1.6  Êý¾Ý´¦Àí  ËùÓÐʵÑéÊý¾Ý¾ùÒÔx¡Às±íʾ£¬spss11.0ͳ¼ÆÈí¼þ´¦ÀíÊý¾Ý£¬·½²î·ÖÎö±È½Ï×é¼ä²îÒ죬p£¼0.05Ϊ²îÒìÓÐÏÔÖøÐÔ¡£
   
    2  ½á¹û
   
    2.1  Ò»°ãÇé¿ö¹Û²ì  µÚ1ÖÜ×¢Éäadrºó£¬³ý¿Õ°×¶ÔÕÕ×éÍ⣬ÆäÓà¸÷×鶯Îï¾ùÓÐÉãʳ¼õÉÙ¡¢ÌåÖØÏ½µ¡¢¸¹Ðº¡¢Ï²òéËõ¡¢ÌåëÁèÂÒÎÞ¹âÔóµÈ±íÏÖ£»ÊµÑéµÚ3ÖÜ£¬Ä£ÐÍ×éÓë¸÷ÖÎÁÆ×é³öÏÖ²»Í¬³Ì¶ÈË®Ö×£¬ÒÔËÄÖ«Ë®Ö×ΪÃ÷ÏÔÖ¢×´£¬Ä£ÐÍ×é2Àý³öÏÖÃ÷ÏÔ¸¹Ë®£»ÊµÑéµÚ4ÖÜ£¬Ä£ÐÍ×éË®Ö×Ã÷ÏÔ£¬¸¹Ë®·¢ÉúÂÊÉÏÉý£¬Ë®Ö×ÂÊ70%£¬¸÷¸øÒ©ÖÎÁÆ×éË®Ö׳̶ÈÃ÷ÏÔÇáÓÚÄ£ÐÍ×飻ʵÑéµÚ5ÖÜ£¬Ä£ÐÍ×éË®Ö×ÎÞÃ÷ÏÔ¸ÄÉÆ£¬¸ÊÜÎÒæÉö¶³¸É·Û¸ß¡¢ÖмÁÁ¿×é¼°Ç¿µÄËÉÖÎÁÆ×éË®Ö×Ïû³ýÃ÷ÏÔ¡£¸÷×éÔìģǰÒÔ¼°¸øÒ©ºóµÚ2¡¢5ÖÜÄ©24hÄòÁ¿Çé¿ö¼û±í1¡£

±í1  ¸÷×éÊÜÊÔ¶¯ÎïÔìģǰÒÔ¼°¸øÒ©ºóµÚ2¡¢5ÖÜÄ©24hÄòÁ¿Çé¿ö  (n£½10£¬x¡Às£©
   

 

×¢£ºÓë¿Õ°×¶ÔÕÕ×é±È½Ï£¬*p£¼0.05£¬**p£¼0.01£»ÓëÄ£ÐÍ×é±È½Ï£¬#p£¼0.05£¬##p£¼0.01

¹²2Ò³: 1 [2] ÏÂÒ»Ò³


ǰÁÐÏÙ°©ÄÚ·ÖÃÚÖÎÁƶÔѪPSAµÄÓ°Ïì¼°ÆäÁÙ´²ÒâÒå
´ÙÑ×ÐÔϸ°ûÒò×ÓIL-18¼°ÆäÓ볦¼²²¡¹ØÏµµÄÑо¿½øÕ¹
¹¤É̹ÜÀí | ¹¤¿ÆÂÛÎÄ | ²ÆÎñ¹ÜÀí | ¹ÜÀíѧ | ¹«¹²¹ÜÀí | ²ÆÕþ˰ÊÕ | ֤ȯ½ðÈÚ | »á¼ÆÉó¼Æ | ¼ÆËã»ú | ·¨ÂÉÂÛÎÄ | ҽҩѧ | ººÓïÑÔÎÄѧ
Éç»áÂÛÎÄ | ¹¤¿ÆÂÛÎÄ | Àí¿ÆÂÛÎÄ | ÎÄ»¯ÂÛÎÄ | ÒÕÊõÂÛÎÄ | ÎÄѧÂÛÎÄ | ÕÜѧÂÛÎÄ | ÕþÖÎÂÛÎÄ | Ó¢ÓïÂÛÎÄ | д×÷Ö¸µ¼ | ¼ÆËã»úÓ¦ÓÃ
www.zlunwen.com ÕÒÂÛÎÄÍø ® °æÈ¨ËùÓÐ ÍøÕ¾µØÍ¼